171 related articles for article (PubMed ID: 12511607)
1. A novel estrogen receptor alpha-associated protein, template-activating factor Ibeta, inhibits acetylation and transactivation.
Loven MA; Muster N; Yates JR; Nardulli AM
Mol Endocrinol; 2003 Jan; 17(1):67-78. PubMed ID: 12511607
[TBL] [Abstract][Full Text] [Related]
2. Thanatos-associated protein 7 associates with template activating factor-Ibeta and inhibits histone acetylation to repress transcription.
Macfarlan T; Parker JB; Nagata K; Chakravarti D
Mol Endocrinol; 2006 Feb; 20(2):335-47. PubMed ID: 16195249
[TBL] [Abstract][Full Text] [Related]
3. A novel estrogen receptor alpha-associated protein alters receptor-deoxyribonucleic acid interactions and represses receptor-mediated transcription.
Loven MA; Davis RE; Curtis CD; Muster N; Yates JR; Nardulli AM
Mol Endocrinol; 2004 Nov; 18(11):2649-59. PubMed ID: 15308690
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of FoxO1 acetylation by INHAT subunit SET/TAF-Iβ induces p21 transcription.
Chae YC; Kim KB; Kang JY; Kim SR; Jung HS; Seo SB
FEBS Lett; 2014 Aug; 588(17):2867-73. PubMed ID: 24983498
[TBL] [Abstract][Full Text] [Related]
5. Activated glucocorticoid receptor interacts with the INHAT component Set/TAF-Ibeta and releases it from a glucocorticoid-responsive gene promoter, relieving repression: implications for the pathogenesis of glucocorticoid resistance in acute undifferentiated leukemia with Set-Can translocation.
Ichijo T; Chrousos GP; Kino T
Mol Cell Endocrinol; 2008 Feb; 283(1-2):19-31. PubMed ID: 18096310
[TBL] [Abstract][Full Text] [Related]
6. Highly acidic C-terminal domain of pp32 is required for the interaction with histone chaperone, TAF-Ibeta.
Lee IS; Oh SM; Kim SM; Lee DS; Seo SB
Biol Pharm Bull; 2006 Dec; 29(12):2395-8. PubMed ID: 17142970
[TBL] [Abstract][Full Text] [Related]
7. Histone acetylation-independent transcription stimulation by a histone chaperone.
Kato K; Miyaji-Yamaguchi M; Okuwaki M; Nagata K
Nucleic Acids Res; 2007; 35(3):705-15. PubMed ID: 17179179
[TBL] [Abstract][Full Text] [Related]
8. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen receptor-alpha with the 3',5'-cyclic adenosine monophosphate response element-binding protein-binding protein/p300 coactivators.
Jaber BM; Gao T; Huang L; Karmakar S; Smith CL
Mol Endocrinol; 2006 Nov; 20(11):2695-710. PubMed ID: 16840538
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Ku70 acetylation by INHAT subunit SET/TAF-Iβ regulates Ku70-mediated DNA damage response.
Kim KB; Kim DW; Park JW; Jeon YJ; Kim D; Rhee S; Chae JI; Seo SB
Cell Mol Life Sci; 2014 Jul; 71(14):2731-45. PubMed ID: 24305947
[TBL] [Abstract][Full Text] [Related]
10. A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression.
Kutney SN; Hong R; Macfarlan T; Chakravarti D
J Biol Chem; 2004 Jul; 279(29):30850-5. PubMed ID: 15136563
[TBL] [Abstract][Full Text] [Related]
11. Identification of distinct SET/TAF-Ibeta domains required for core histone binding and quantitative characterisation of the interaction.
Karetsou Z; Emmanouilidou A; Sanidas I; Liokatis S; Nikolakaki E; Politou AS; Papamarcaki T
BMC Biochem; 2009 Apr; 10():10. PubMed ID: 19358706
[TBL] [Abstract][Full Text] [Related]
12. H3K27 methylation and H3S28 phosphorylation-dependent transcriptional regulation by INHAT subunit SET/TAF-Iβ.
Kim JY; Kim KB; Son HJ; Chae YC; Oh ST; Kim DW; Pak JH; Seo SB
FEBS Lett; 2012 Sep; 586(19):3159-65. PubMed ID: 22796192
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for inhibition of the histone chaperone activity of SET/TAF-Iβ by cytochrome c.
González-Arzola K; Díaz-Moreno I; Cano-González A; Díaz-Quintana A; Velázquez-Campoy A; Moreno-Beltrán B; López-Rivas A; De la Rosa MA
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9908-13. PubMed ID: 26216969
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor accessibility and histone acetylation of the progesterone receptor gene differs between parental MCF-7 cells and a subline that has lost progesterone receptor expression.
Xu X; Murdoch FE; Curran EM; Welshons WV; Fritsch MK
Gene; 2004 Mar; 328():143-51. PubMed ID: 15019994
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus type 1 tegument protein VP22 interacts with TAF-I proteins and inhibits nucleosome assembly but not regulation of histone acetylation by INHAT.
van Leeuwen H; Okuwaki M; Hong R; Chakravarti D; Nagata K; O'Hare P
J Gen Virol; 2003 Sep; 84(Pt 9):2501-2510. PubMed ID: 12917472
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
17. Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation.
Cavarretta IT; Mukopadhyay R; Lonard DM; Cowsert LM; Bennett CF; O'Malley BW; Smith CL
Mol Endocrinol; 2002 Feb; 16(2):253-70. PubMed ID: 11818499
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-alpha protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary.
Alarid ET; Preisler-Mashek MT; Solodin NM
Endocrinology; 2003 Aug; 144(8):3469-76. PubMed ID: 12865327
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor alpha and estrogen receptor-related receptor alpha1 compete for binding and coactivator.
Zhang Z; Teng CT
Mol Cell Endocrinol; 2001 Feb; 172(1-2):223-33. PubMed ID: 11165056
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation.
Oesterreich S; Zhang Q; Hopp T; Fuqua SA; Michaelis M; Zhao HH; Davie JR; Osborne CK; Lee AV
Mol Endocrinol; 2000 Mar; 14(3):369-81. PubMed ID: 10707955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
